You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

GYNE-LOTRIMIN 3 COMBINATION PACK Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Gyne-lotrimin 3 Combination Pack patents expire, and when can generic versions of Gyne-lotrimin 3 Combination Pack launch?

Gyne-lotrimin 3 Combination Pack is a drug marketed by Bayer Healthcare Llc and is included in one NDA.

The generic ingredient in GYNE-LOTRIMIN 3 COMBINATION PACK is clotrimazole. There are eleven drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the clotrimazole profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Gyne-lotrimin 3 Combination Pack

A generic version of GYNE-LOTRIMIN 3 COMBINATION PACK was approved as clotrimazole by P AND L on July 16th, 1993.

  Try a Trial

US Patents and Regulatory Information for GYNE-LOTRIMIN 3 COMBINATION PACK

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Healthcare Llc GYNE-LOTRIMIN 3 COMBINATION PACK clotrimazole CREAM, TABLET;TOPICAL, VAGINAL 020526-002 Jul 29, 1996 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.